Insider · CIK 0001321402
Michael Raab
ceopresidentofficerdirector
Files at FOLD (AMICUS THERAPEUTICS, INC.), ARDX (ARDELYX, INC.). First filing Oct 15, 2024, latest Aug 25, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 14
$0 bought, $2.3M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ARDX: ARDELYX, INC.
ARDXOct 9, 2026 · close 3.28
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | ARDELYX, INC. | $271k 45,687 shares | -3% | +86% from low-12% from high | |
| 52Moderate | ARDELYX, INC. | $191k 46,817 shares | -3% | +27% from low-40% from high | |
| 2Weak | ARDELYX, INC. | $177k 41,666 shares | -3% | 0% from low-40% from high | |
| 2Weak | ARDELYX, INC. | $191k 41,666 shares | -3% | +1% from low-34% from high | |
| 2Weak | ARDELYX, INC. | $223k 41,668 shares | -2% | +18% from low-24% from high | |
| 51Moderate | ARDELYX, INC. | $129k 22,964 shares | -2% | +27% from low-17% from high | |
| 2Weak | ARDELYX, INC. | $223k 41,666 shares | -4% | +19% from low-23% from high | |
| 2Weak | ARDELYX, INC. | $221k 41,666 shares | -4% | +20% from low-22% from high | |
| 1Weak | ARDELYX, INC. | $132k 25,000 shares | -2% | - | |
| 31Weak | ARDELYX, INC. | $134k 25,000 shares | -2% | - | |
| 51Moderate | ARDELYX, INC. | $153k 31,980 shares | -3% | - | |
| 20Weak | ARDELYX, INC. | $13k 2,743 shares | -0% | - | |
| 9Weak | ARDELYX, INC. | $148k 25,000 shares | -2% | - | |
| 11Weak | ARDELYX, INC. | $45k 7,500 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | ARDX ARDELYX, INC. | SOpen-market sale Common Stock | -45,687 | $5.93 | $271k | 1,502,250 | Aug 25, 2025 |
| Jun 5, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock | +20,414 | $0.00 | $0 | 115,857 | Jun 6, 2025 |
| Jun 5, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Stock Options (right to buy)derivative | +74,872 | $0.00 | $0 | 74,872 | Jun 6, 2025 |
| May 20, 2025 | ARDX ARDELYX, INC. | SOpen-market sale Common Stock | -46,817 | $4.08 | $191k | 1,547,937 | May 22, 2025 |
| May 2, 2025 | ARDX ARDELYX, INC. | MOption exercise Common Stock10b5-1 | +20,833 | $0.99 | $21k | 1,636,420 | May 5, 2025 |
| May 2, 2025 | ARDX ARDELYX, INC. | SOpen-market sale Common Stock10b5-1 | -41,666 | $4.25 | $177k | 1,594,754 | May 5, 2025 |
| May 2, 2025 | ARDX ARDELYX, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,833 | $0.00 | $0 | 415,834 | May 5, 2025 |
| Apr 4, 2025 | ARDX ARDELYX, INC. | MOption exercise Common Stock10b5-1 | +20,833 | $0.99 | $21k | 1,657,253 | Apr 8, 2025 |
| Apr 4, 2025 | ARDX ARDELYX, INC. | SOpen-market sale Common Stock10b5-1 | -41,666 | $4.59 | $191k | 1,615,587 | Apr 8, 2025 |
| Apr 4, 2025 | ARDX ARDELYX, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,833 | $0.00 | $0 | 436,667 | Apr 8, 2025 |
| Mar 7, 2025 | ARDX ARDELYX, INC. | MOption exercise Common Stock10b5-1 | +20,834 | $0.99 | $21k | 1,676,806 | Mar 7, 2025 |
| Mar 7, 2025 | ARDX ARDELYX, INC. | SOpen-market sale Common Stock10b5-1 | -41,668 | $5.36 | $223k | 1,635,138 | Mar 7, 2025 |
| Mar 7, 2025 | ARDX ARDELYX, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,834 | $0.00 | $0 | 457,500 | Mar 7, 2025 |
| Feb 25, 2025 | ARDX ARDELYX, INC. | AGrant or award Common Stock | +570,217 | $0.00 | $0 | 1,655,972 | Feb 27, 2025 |
| Feb 25, 2025 | ARDX ARDELYX, INC. | AGrant or award Stock Option (Right to Buy)derivative | +855,326 | $0.00 | $0 | 855,326 | Feb 27, 2025 |
| Feb 20, 2025 | ARDX ARDELYX, INC. | SOpen-market sale Common Stock | -22,964 | $5.62 | $129k | 1,085,755 | Feb 21, 2025 |
| Jan 31, 2025 | ARDX ARDELYX, INC. | MOption exercise Common Stock10b5-1 | +20,833 | $0.99 | $21k | 1,150,385 | Jan 31, 2025 |
| Jan 31, 2025 | ARDX ARDELYX, INC. | SOpen-market sale Common Stock10b5-1 | -41,666 | $5.36 | $223k | 1,108,719 | Jan 31, 2025 |
| Jan 31, 2025 | ARDX ARDELYX, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,833 | $0.00 | $0 | 478,334 | Jan 31, 2025 |
| Jan 7, 2025 | ARDX ARDELYX, INC. | MOption exercise Common Stock10b5-1 | +20,833 | $0.99 | $21k | 1,171,218 | Jan 10, 2025 |
| Jan 7, 2025 | ARDX ARDELYX, INC. | SOpen-market sale Common Stock10b5-1 | -41,666 | $5.31 | $221k | 1,129,552 | Jan 10, 2025 |
| Jan 7, 2025 | ARDX ARDELYX, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,833 | $0.00 | $0 | 499,167 | Jan 10, 2025 |
| Dec 10, 2024 | ARDX ARDELYX, INC. | MOption exercise Common Stock10b5-1 | +25,000 | $0.99 | $25k | 1,175,385 | Dec 12, 2024 |
| Dec 10, 2024 | ARDX ARDELYX, INC. | SOpen-market sale Common Stock10b5-1 | -25,000 | $5.26 | $132k | 1,150,385 | Dec 12, 2024 |
| Dec 10, 2024 | ARDX ARDELYX, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -25,000 | $0.00 | $0 | 520,000 | Dec 12, 2024 |
| Nov 25, 2024 | ARDX ARDELYX, INC. | SOpen-market sale Common Stock10b5-1 | -25,000 | $5.38 | $134k | 1,150,385 | Nov 27, 2024 |
| Nov 20, 2024 | ARDX ARDELYX, INC. | SOpen-market sale Common Stock | -31,980 | $4.79 | $153k | 1,175,385 | Nov 22, 2024 |
| Nov 11, 2024 | ARDX ARDELYX, INC. | SOpen-market sale Common Stock10b5-1 | -2,743 | $4.90 | $13k | 1,207,365 | Nov 12, 2024 |
| Oct 28, 2024 | ARDX ARDELYX, INC. | MOption exercise Common Stock10b5-1 | +25,000 | $0.99 | $25k | 1,235,108 | Oct 31, 2024 |
| Oct 28, 2024 | ARDX ARDELYX, INC. | SOpen-market sale Common Stock10b5-1 | -25,000 | $5.91 | $148k | 1,210,108 | Oct 31, 2024 |
| Oct 28, 2024 | ARDX ARDELYX, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -25,000 | $0.00 | $0 | 545,000 | Oct 31, 2024 |
| Oct 11, 2024 | ARDX ARDELYX, INC. | SOpen-market sale Common Stock10b5-1 | -7,500 | $6.01 | $45k | 1,210,108 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.